{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:27:13Z","timestamp":1777454833915,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.intimp.2024.113580","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T07:25:01Z","timestamp":1731655501000},"page":"113580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P3","title":["Evidence of the \u201chit and run\u201d characteristics of Cerebroprotein Hydrolysate-I in the treatment of neonatal HIE based on pharmacokinetic and pharmacological studies"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0994-7597","authenticated-orcid":false,"given":"Tingting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianzhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laipeng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.113580_b0005","doi-asserted-by":"crossref","unstructured":"M. Douglas-Escobar, M.J.J.p. Weiss, Hypoxic-ischemic encephalopathy: a review for the clinician, 169(4) (2015) 397-403.","DOI":"10.1001\/jamapediatrics.2014.3269"},{"key":"10.1016\/j.intimp.2024.113580_b0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fped.2016.00114","article-title":"Preterm Hypoxic-Ischemic Encephalopathy","volume":"4","author":"Gopagondanahalli","year":"2016","journal-title":"Front. Pediatr."},{"issue":"2","key":"10.1016\/j.intimp.2024.113580_b0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.earlhumdev.2004.06.003","article-title":"Hypoxic-ischemic brain injury in the term infant-current concepts","volume":"80","author":"Shalak","year":"2004","journal-title":"Early Hum. Dev."},{"issue":"8","key":"10.1016\/j.intimp.2024.113580_b0020","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.21037\/tp-23-253","article-title":"A narrative review on treatment strategies for neonatal hypoxic ischemic encephalopathy","volume":"12","author":"Korf","year":"2023","journal-title":"Translational Pediatrics"},{"issue":"7","key":"10.1016\/j.intimp.2024.113580_b0025","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/0883073819828625","article-title":"Current Practice of Therapeutic Hypothermia for Mild Hypoxic Ischemic Encephalopathy","volume":"34","author":"Saw","year":"2019","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.intimp.2024.113580_b0030","doi-asserted-by":"crossref","unstructured":"V. Oliveira, J.R. Kumutha, N. E, et al., Hypothermia for encephalopathy in low-income and middle-income countries: feasibility of whole-body cooling using a low-cost servo-controlled device, BMJ paediatrics open 2(1) (2018) e000245.","DOI":"10.1136\/bmjpo-2017-000245"},{"issue":"9","key":"10.1016\/j.intimp.2024.113580_b0035","doi-asserted-by":"crossref","first-page":"e1273","DOI":"10.1016\/S2214-109X(21)00264-3","article-title":"Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri Lanka, and Bangladesh","volume":"9","author":"Thayyil","year":"2021","journal-title":"Lancet Glob. Health"},{"issue":"5","key":"10.1016\/j.intimp.2024.113580_b0040","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/14737175.2017.1259567","article-title":"Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment","volume":"17","author":"Y\u0131ld\u0131z","year":"2017","journal-title":"Expert Rev. Neurother."},{"issue":"9","key":"10.1016\/j.intimp.2024.113580_b0045","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00424-023-02837-5","article-title":"Oligodendrocyte precursor cells: the multitaskers in the brain","volume":"475","author":"Fang","year":"2023","journal-title":"Pflugers Arch."},{"issue":"7","key":"10.1016\/j.intimp.2024.113580_b0050","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s12264-021-00693-w","article-title":"Oligodendroglial GABAergic Signaling: More Than Inhibition!","volume":"37","author":"Bai","year":"2021","journal-title":"Neurosci. Bull."},{"issue":"1","key":"10.1016\/j.intimp.2024.113580_b0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0166-2236(00)01691-X","article-title":"The oligodendrocyte precursor cell in health and disease","volume":"24","author":"Levine","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.intimp.2024.113580_b0060","first-page":"193","article-title":"Remyelination in experimental models of toxin-induced demyelination","volume":"318","author":"Blakemore","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113580_b0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.22627","article-title":"Arrested preoligodendrocyte maturation contributes to myelination failure in premature infants","volume":"71","author":"Buser","year":"2012","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113580_b0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1750-3639.2007.00107.x","article-title":"Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia","volume":"18","author":"Billiards","year":"2008","journal-title":"Brain Pathology (zurich, Switzerland)"},{"issue":"1","key":"10.1016\/j.intimp.2024.113580_b0075","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191365","article-title":"Histamine H2 receptor negatively regulates oligodendrocyte differentiation in neonatal hypoxic-ischemic white matter injury","volume":"218","author":"Jiang","year":"2021","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.intimp.2024.113580_b0080","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","article-title":"Therapeutic peptides: Historical perspectives, current development trends, and future directions","volume":"26","author":"Lau","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2024.113580_b0085","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.intimp.2024.113580_b0090","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JAD-220575","article-title":"Modulation of Amyloid-\u03b2 and Tau in Alzheimer's Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin\u00ae and Donepezil","volume":"90","author":"Alvarez","year":"2022","journal-title":"Journal of Alzheimer's Disease : JAD"},{"key":"10.1016\/j.intimp.2024.113580_b0095","doi-asserted-by":"crossref","unstructured":"S.Z. Mitrovi\u0107, L.M. Konstantinovi\u0107, V. Miler Jerkovi\u0107, et al., Extended Poststroke Rehabilitation Combined with Cerebrolysin Promotes Upper Limb Motor Recovery in Early Subacute Phase of Rehabilitation: A Randomized Clinical Study, Medicina (Kaunas, Lithuania) 59(2) (2023).","DOI":"10.3390\/medicina59020291"},{"issue":"4","key":"10.1016\/j.intimp.2024.113580_b0100","first-page":"629","article-title":"Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of","volume":"39","author":"Bornstein","year":"2018","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.intimp.2024.113580_b0105","first-page":"132","article-title":"Cerebroprotein hydrolysate: Innovation in the treatment of neurodegenerative disorders, Journal, Indian Academy of","volume":"15","author":"Gupta","year":"2014","journal-title":"Clin. Med."},{"issue":"7","key":"10.1016\/j.intimp.2024.113580_b0110","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1002\/fsn3.2333","article-title":"Cerebroprotein hydrolysate-I protects senescence-induced by D-galactose in PC12 cells and mice","volume":"9","author":"Zhu","year":"2021","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.intimp.2024.113580_b0115","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2147\/NDT.S313807","article-title":"The Cerebroprotein Hydrolysate-I Plays a Neuroprotective Effect on Cerebral Ischemic Stroke by Inhibiting MEK\/ERK1\/2 Signaling Pathway in Rats","volume":"17","author":"Ren","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.intimp.2024.113580_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120568","article-title":"Cerebroprotein hydrolysate injection is involved in promoting long-term angiogenesis, vessel diameter and density after cerebral ischemia in mice","volume":"300","author":"Myagmar","year":"2022","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.intimp.2024.113580_b0125","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1124\/dmd.123.001443","article-title":"Identification and Validation of Active Ingredient in Cerebrotein Hydrolysate-I Based on Pharmacokinetic and Pharmacodynamic Studies","volume":"51","author":"Guo","year":"2023","journal-title":"Drug Metab. Dispos."},{"issue":"30","key":"10.1016\/j.intimp.2024.113580_b0130","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1016\/j.chroma.2010.05.056","article-title":"Qualitative and quantitative determination of complicated herbal components by liquid chromatography hybrid ion trap time-of-flight mass spectrometry and a relative exposure approach to herbal pharmacokinetics independent of standards","volume":"1217","author":"Liang","year":"2010","journal-title":"J. Chromatogr. A"},{"issue":"5","key":"10.1016\/j.intimp.2024.113580_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10050937","article-title":"Experimental Models for Testing the Efficacy of Pharmacological Treatments for Neonatal Hypoxic-Ischemic Encephalopathy","volume":"10","author":"Landucci","year":"2022","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.intimp.2024.113580_b0140","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/aps.2013.89","article-title":"Inflammatory responses in hypoxic ischemic encephalopathy","volume":"34","author":"Liu","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.intimp.2024.113580_b0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1203\/PDR.0b013e3181df5f6b","article-title":"Low-dose lipopolysaccharide selectively sensitizes hypoxic ischemia-induced white matter injury in the immature brain","volume":"68","author":"Wang","year":"2010","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.intimp.2024.113580_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.341272","article-title":"Strategies for mapping protein hydrolysate profiles and pharmacokinetics based on non-targeted proteomics combining skyline-aided quantitative techniques","volume":"1265","author":"Mao","year":"2023","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.intimp.2024.113580_b0155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2018.06.015","article-title":"Glycogen synthase kinase-3\u03b2 inhibition enhances myelination in preterm newborns with intraventricular hemorrhage, but not recombinant Wnt3A","volume":"118","author":"Dohare","year":"2018","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.intimp.2024.113580_b0160","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00401-017-1718-6","article-title":"White matter injury in the preterm infant: pathology and mechanisms","volume":"134","author":"Back","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113580_b0165","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/bpa.12798","article-title":"Complement C3a induces axonal hypomyelination in the periventricular white matter through activation of WNT\/\u03b2-catenin signal pathway in septic neonatal rats experimentally induced by lipopolysaccharide","volume":"30","author":"Huang","year":"2020","journal-title":"Brain Pathology (zurich, Switzerland)"},{"issue":"3","key":"10.1016\/j.intimp.2024.113580_b0170","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00431-021-04320-8","article-title":"New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy","volume":"181","author":"Victor","year":"2022","journal-title":"Eur. J. Pediatr."},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2024.113580_b0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/pr.2013.206","article-title":"Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990","volume":"1","author":"Lee","year":"2013","journal-title":"Pediatric Research 74 Suppl"},{"issue":"19","key":"10.1016\/j.intimp.2024.113580_b0180","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMra041996","article-title":"Neonatal brain injury","volume":"351","author":"Ferriero","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.intimp.2024.113580_b0185","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1001\/jama.2014.16058","article-title":"Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial","volume":"312","author":"Shankaran","year":"2014","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.intimp.2024.113580_b0190","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa1112066","article-title":"Childhood outcomes after hypothermia for neonatal encephalopathy","volume":"366","author":"Shankaran","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.113580_b0195","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2147\/NDT.S311760","article-title":"Cerebroprotein Hydrolysate-I Inhibits Hippocampal Neuronal Apoptosis by Activating PI3K\/Akt Signaling Pathway in Vascular Dementia Mice","volume":"17","author":"Wu","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.intimp.2024.113580_b0200","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.2147\/NDT.S289990","article-title":"A Novel Cerebroprotein Hydrolysate, CH1, Ameliorates Chronic Focal Cerebral Ischemia Injury by Promoting White Matter Integrity via the Shh\/Ptch-1\/Gli-1 Signaling Pathway","volume":"16","author":"Cao","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"3","key":"10.1016\/j.intimp.2024.113580_b0205","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/00207454.2020.1738431","article-title":"Neuroprotective effects of troxerutin and cerebroprotein hydrolysate injection on the neurovascular unit in a rat model of Middle cerebral artery occlusion","volume":"131","author":"Zh\u00e0o","year":"2021","journal-title":"Int. J. Neurosci."},{"issue":"9","key":"10.1016\/j.intimp.2024.113580_b0210","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s41423-019-0257-6","article-title":"MiRNA-210 induces microglial activation and regulates microglia-mediated neuroinflammation in neonatal hypoxic-ischemic encephalopathy","volume":"17","author":"Li","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113580_b0215","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/a-0790-8200","article-title":"Safranal Attenuates Excitotoxin-Induced Oxidative OLN-93 Cells Injury","volume":"69","author":"Alavi","year":"2019","journal-title":"Drug Research"},{"issue":"2","key":"10.1016\/j.intimp.2024.113580_b0220","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8","article-title":"OLN-93: a new permanent oligodendroglia cell line derived from primary rat brain glial cultures","volume":"45","author":"Richter-Landsberg","year":"1996","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.intimp.2024.113580_b0225","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuropharm.2017.01.028","article-title":"FTY720 (Fingolimod) reverses \u03b1-synuclein-induced downregulation of brain-derived neurotrophic factor mRNA in OLN-93 oligodendroglial cells","volume":"117","author":"Segura-Ulate","year":"2017","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.intimp.2024.113580_b0230","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nn.3676","article-title":"Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer","volume":"17","author":"Fancy","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.intimp.2024.113580_b0235","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nn.4200","article-title":"Remodeling myelination: implications for mechanisms of neural plasticity","volume":"19","author":"Chang","year":"2016","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.intimp.2024.113580_b0240","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.neuron.2018.07.017","article-title":"Enhancing Oligodendrocyte Myelination Rescues Synaptic Loss and Improves Functional Recovery after Chronic Hypoxia","volume":"99","author":"Wang","year":"2018","journal-title":"Neuron"},{"issue":"Pt 7","key":"10.1016\/j.intimp.2024.113580_b0245","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/brain\/awn096","article-title":"Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis","volume":"131","author":"Kuhlmann","year":"2008","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.intimp.2024.113580_b0250","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s12035-013-8584-6","article-title":"Wnt signaling in remyelination in multiple sclerosis: friend or foe?","volume":"49","author":"Xie","year":"2014","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113580_b0255","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073798","article-title":"Cannabidiol and the Canonical WNT\/\u03b2-Catenin Pathway in Glaucoma","volume":"22","author":"Vall\u00e9e","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5663","key":"10.1016\/j.intimp.2024.113580_b0260","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1126\/science.1094291","article-title":"Convergence of Wnt, beta-catenin, and cadherin pathways","volume":"303","author":"Nelson","year":"2004","journal-title":"Science (new York, n.y.)"},{"key":"10.1016\/j.intimp.2024.113580_b0265","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biochi.2023.03.001","article-title":"Wnt\/\u03b2-catenin signaling pathway-a versatile player in apoptosis and autophagy","volume":"211","author":"Ma","year":"2023","journal-title":"Biochimie"},{"issue":"8","key":"10.1016\/j.intimp.2024.113580_b0270","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1016\/j.apsb.2023.04.009","article-title":"Schisandra lignans ameliorate nonalcoholic steatohepatitis by regulating aberrant metabolism of phosphatidylethanolamines","volume":"13","author":"Xue","year":"2023","journal-title":"Acta Pharm. Sin. B"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924021027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924021027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T04:24:46Z","timestamp":1733977486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924021027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":54,"alternative-id":["S1567576924021027"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113580","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence of the \u201chit and run\u201d characteristics of Cerebroprotein Hydrolysate-I in the treatment of neonatal HIE based on pharmacokinetic and pharmacological studies","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113580"}}